Dear Sir We have included the Declaration to the effect that Auditor''s Report on Audited Financial Results is with unmodified opinion in this revised outcome of the Board meeting held ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 6.8 pts less than Nifty Microcap 250 and 6.5 pts less than its Commodity Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
TCM Limited's board approved audited standalone and consolidated financial results for FY25 on 29 May 2025, with statutory auditor SGM & Associates LLP issuing an unmodified opinion on both sets of results. Standalone revenue from operations fell to ₹2,472.74 lakhs from ₹3,164.73 lakhs in FY24 (down ~22%), while standalone profit after tax jumped to ₹314.92 lakhs from ₹20.36 lakhs, taking EPS to ₹4.21. Consolidated revenue declined to ₹2,600.61 lakhs from ₹3,223.19 lakhs, but the group swung to a profit of ₹139.93 lakhs versus a loss of ₹228.92 lakhs last year. The sharp profit surge was largely driven by a one-time write-back of ₹422.96 lakhs of old liabilities related to a dropped real estate development deal in Kalamassery, Kerala. Operating cash flow turned sharply negative at -₹1,078.75 lakhs (standalone) and -₹1,007.76 lakhs (consolidated), and short-term borrowings spiked from ₹16.63 lakhs to ₹1,115.90 lakhs.
Headline earnings look strong but are flattered by a one-off liability write-back rather than core business growth; weakening revenue, negative operating cash flow and a sharp rise in short-term debt suggest underlying pressure, which investors should weigh against the real estate segment's improving performance and the ₹519.81 lakhs commercial property being repositioned as investment property for leasing.